| 000 | 01001 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250515161545.0 | ||
| 264 | 0 | _c20090303 | |
| 008 | 200903s 0 0 eng d | ||
| 022 | _a1533-4406 | ||
| 024 | 7 |
_a10.1056/NEJMc082718 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDevos, David | |
| 245 | 0 | 0 |
_aLevodopa for Parkinson's disease. _h[electronic resource] |
| 260 |
_bThe New England journal of medicine _cFeb 2009 |
||
| 300 |
_a935-6; author reply 936 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 |
_aAntiparkinson Agents _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Parenteral |
| 650 | 0 | 4 |
_aLevodopa _xadministration & dosage |
| 650 | 0 | 4 |
_aParkinson Disease _xdrug therapy |
| 700 | 1 | _aMoreau, Caroline | |
| 700 | 1 | _aDestée, Alain | |
| 773 | 0 |
_tThe New England journal of medicine _gvol. 360 _gno. 9 _gp. 935-6; author reply 936 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1056/NEJMc082718 _zAvailable from publisher's website |
| 999 |
_c18687970 _d18687970 |
||